Published in Circ Res on March 08, 2002
Regulation of blood pressure and salt homeostasis by endothelin. Physiol Rev (2011) 2.22
Angiotensin II and angiotensin II receptor blocker modulate the arrhythmogenic activity of pulmonary veins. Br J Pharmacol (2006) 0.92
Mineralocorticoid receptor activation is crucial in the signalling pathway leading to the Anrep effect. J Physiol (2011) 0.81
Na(+)-Ca2+ exchange function underlying contraction frequency inotropy in the cat myocardium. J Physiol (2003) 0.79
N-n-butyl haloperidol iodide inhibits H2O2-induced Na+/Ca2+-exchanger activation via the Na+/H+ exchanger in rat ventricular myocytes. Drug Des Devel Ther (2014) 0.78
Peptide Lv augments L-type voltage-gated calcium channels through vascular endothelial growth factor receptor 2 (VEGFR2) signaling. Biochim Biophys Acta (2015) 0.75
Endurance training in the spontaneously hypertensive rat: conversion of pathological into physiological cardiac hypertrophy. Hypertension (2009) 1.22
The positive inotropic effect of angiotensin II: role of endothelin-1 and reactive oxygen species. Hypertension (2006) 0.98
Na+/H+ exchanger-1 inhibitors decrease myocardial superoxide production via direct mitochondrial action. J Appl Physiol (1985) (2008) 0.98
Myocardial hypertrophy of normotensive Wistar-Kyoto rats. Am J Physiol Heart Circ Physiol (2003) 0.97
Phosphodiesterase 5A inhibition induces Na+/H+ exchanger blockade and protection against myocardial infarction. Hypertension (2007) 0.92
Mitochondrial reactive oxygen species activate the slow force response to stretch in feline myocardium. J Physiol (2007) 0.91
Aldosterone stimulates the cardiac Na(+)/H(+) exchanger via transactivation of the epidermal growth factor receptor. Hypertension (2011) 0.91
The Anrep effect requires transactivation of the epidermal growth factor receptor. J Physiol (2010) 0.91
Regression of isoproterenol-induced cardiac hypertrophy by Na+/H+ exchanger inhibition. Hypertension (2003) 0.90
Silencing of cardiac mitochondrial NHE1 prevents mitochondrial permeability transition pore opening. Am J Physiol Heart Circ Physiol (2011) 0.88
Regression of cardiomyocyte hypertrophy in SHR following chronic inhibition of the Na(+)/H(+) exchanger. Cardiovasc Res (2002) 0.88
Normalization of the calcineurin pathway underlies the regression of hypertensive hypertrophy induced by Na+/H+ exchanger-1 (NHE-1) inhibition. Can J Physiol Pharmacol (2007) 0.87
Endothelin isoforms and the response to myocardial stretch. Am J Physiol Heart Circ Physiol (2005) 0.86
Antibodies against the cardiac sodium/bicarbonate co-transporter (NBCe1) as pharmacological tools. Br J Pharmacol (2011) 0.86
Effects of different fractions of a red wine non-alcoholic extract on ischemia-reperfusion injury. Life Sci (2005) 0.85
Cardioprotection from ischemia/reperfusion induced by red wine extract is mediated by K(ATP) channels. J Cardiovasc Pharmacol (2002) 0.85
A low dose of angiotensin II increases inotropism through activation of reverse Na(+)/Ca(2+) exchange by endothelin release. Cardiovasc Res (2003) 0.85
Na+/H+ exchanger inhibition at the onset of reperfusion decreases myocardial infarct size: role of reactive oxygen species. Cardiovasc Pathol (2006) 0.85
In vivo key role of reactive oxygen species and NHE-1 activation in determining excessive cardiac hypertrophy. Pflugers Arch (2011) 0.82
Mitochondrial NHE1: a newly identified target to prevent heart disease. Front Physiol (2013) 0.82
Myocardial reperfusion injury: reactive oxygen species vs. NHE-1 reactivation. Cell Physiol Biochem (2011) 0.82
Mineralocorticoid receptor activation is crucial in the signalling pathway leading to the Anrep effect. J Physiol (2011) 0.81
Silencing of NHE-1 blunts the slow force response to myocardial stretch. J Appl Physiol (1985) (2011) 0.81
Endogenous endothelin 1 mediates angiotensin II-induced hypertrophy in electrically paced cardiac myocytes through EGFR transactivation, reactive oxygen species and NHE-1. Pflugers Arch (2013) 0.80
Na(+)-H(+) exchanger inhibition: a new antihypertrophic tool. Circ Res (2002) 0.79
[Angiotensin II-induced endothelin-1 release in cardiac myocytes]. Medicina (B Aires) (2006) 0.79
Myocardial mineralocorticoid receptor activation by stretching and its functional consequences. Hypertension (2013) 0.77
Upregulation of myocardial Na+/H+ exchanger induced by chronic treatment with a selective inhibitor. J Mol Cell Cardiol (2002) 0.77
A possible subcellular mechanism underlying the "French paradox": the opening of mitochondrial K(ATP) channels. Appl Physiol Nutr Metab (2011) 0.77
Silencing of sodium/hydrogen exchanger in the heart by direct injection of naked siRNA. J Appl Physiol (1985) (2011) 0.77
The autocrine/paracrine loop after myocardial stretch: mineralocorticoid receptor activation. Curr Cardiol Rev (2013) 0.77
Phosphodiesterase 5A inhibition decreases NHE-1 activity without altering steady state pH(i): role of phosphatases. Cell Physiol Biochem (2010) 0.76
Comparison of the effects of different magnesium administration times on infarct size. Exp Clin Cardiol (2003) 0.75
Effects of antihypertensive therapy on cardiac sodium/hydrogen ion exchanger activity and hypertrophy in spontaneously hypertensive rats. Can J Cardiol (2002) 0.75
[Basic research in Medicine]. Medicina (B Aires) (2010) 0.75
Endothelin 1 versus endothelin 3 in the development of the slow force response to myocardial stretch. Can J Cardiol (2005) 0.75
Decreased activity of the Na+/H+ exchanger by phosphodiesterase 5A inhibition is attributed to an increase in protein phosphatase activity. Hypertension (2010) 0.75